Skip to main content
Premium Trial:

Request an Annual Quote

Aclara BioSciences

Premium

Ž Aclara BioSciences of Mountain View, Calif., launched its IPO last week and saw its shares rise 53 percent from 21 to 32 1/8 in its first trading day, sa

id a Bloomberg report. The genomics and diagnostic tools provider sold 9 million shares and raised $189 million for the 29 percent stake.

Filed under

The Scan

Missed Early Cases

A retrospective analysis of blood samples suggests early SARS-CoV-2 infections may have been missed in the US, the New York Times reports.

Limited Journal Editor Diversity

A survey finds low diversity among scientific and medical journal editors, according to The Scientist.

How Much of a Threat?

Science writes that need for a provision aimed at shoring up genomic data security within a new US bill is being questioned.

PNAS Papers on Historic Helicobacter Spread, Brain Development, C. difficile RNAs

In PNAS this week: Helicobacter genetic diversity gives insight into human migrations, gene expression patterns of brain development, and more.